Urinary biomarkers of kidney injury in patients treated with anti-VEGF drugs

Background. Antiangiogenic drugs are widely used in oncological practice and are aimed at inhibiting angiogenesis. Despite the high antitumor efficacy, their use may be limited by nephrotoxicity, and therefore the search for early biomarkers of kidney damage remains relevant, which will preserve a f...

Full description

Bibliographic Details
Main Authors: Katerina S. Grechukhina, Natalia V. Chebotareva, Liudmila G. Zhukova, Tatiana V. Androsova, Vladimir V. Karpov, Tatiana N. Krasnova
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2022-08-01
Series:Терапевтический архив
Subjects:
Online Access:https://ter-arkhiv.ru/0040-3660/article/viewFile/109608/83862